Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders, with no cure and preventive therapy. Misfolding and extracellular aggregation of Amyloid-β (Aβ) peptides are recognized as the main cause of AD progression, leading to the formation of toxic Aβ oligomers and to the depos...
Main Authors: | Katiuscia Pagano, Simona Tomaselli, Henriette Molinari, Laura Ragona |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2020.619667/full |
Similar Items
-
Multicomponent Synthesis of Polyphenols and Their In Vitro Evaluation as Potential β-Amyloid Aggregation Inhibitors
by: Denise Galante, et al.
Published: (2019-07-01) -
NMR structure of the water soluble Aβ17–34 peptide
by: Genadiy Fonar, et al.
Published: (2014-11-01) -
β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
by: Xiaojuan eSun, et al.
Published: (2015-09-01) -
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
by: Matthew L. Hemming, et al.
Published: (2007-04-01) -
Exploring the Early Stages of the Amyloid Aβ(1–42) Peptide Aggregation Process: An NMR Study
by: Angelo Santoro, et al.
Published: (2021-07-01)